Time to all-cause discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia

被引：0
|
作者：
Swartz, MS
Ascher-Svanum, H
Faries, DE
Tunis, SL
Landbloom, R
Swanson, J
机构：
[1] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA
[2] Eli Lilly & Co, Outcomes Res, Indianapolis, IN 46285 USA
[3] Eli Lilly & Co, Neurosci, Indianapolis, IN 46285 USA
来源：
BIOLOGICAL PSYCHIATRY | 2005年 / 57卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
153
引用
收藏
页码：44S / 44S
页数：1
相关论文
共 50 条
  • [41] Tardive dyskinesia with typical versus atypical antipsychotics
    Jeste, DV
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S55 - S55
  • [42] Typical Versus Atypical Antipsychotics for Acute Mania
    Medici, Clara Reece
    Kai, Linda Marie
    Kristensen, Simon Bang
    Kirkedal, Christian
    Munk-Jorgensen, Povl
    Straszek, Sune
    AMERICAN JOURNAL OF THERAPEUTICS, 2020, 27 (03) : E243 - E248
  • [43] Time to study discontinuation, relapse, and compliance with atypical or conventional antipsychotics in schizophrenia and related disorders
    Glick, ID
    Berg, PH
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 (02) : 65 - 68
  • [44] Gender differences in treatment response to typical and atypical antipsychotics in a sample of outpatients with schizophrenia
    Usall, J
    Suárez, D
    Haro, JM
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 98 - 98
  • [45] Atypical antipsychotics cause diabetes mellitus in schizophrenia?
    Reactions Weekly, 2001, 853 (1) : 3 - 3
  • [46] Long-Acting Typical and Atypical Antipsychotics in Treatment of Schizophrenia: A Retrospective Comparison
    Virit, Osman
    Altindag, Abdurrahman
    Bulbul, Feridun
    Savas, Haluk Asuman
    Dalkilic, Alican
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 19 (02): : 119 - 127
  • [47] The effects of typical and atypical antipsychotics on the cytokine network in schizophrenia
    Rapaport, MH
    Bresee, CJ
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S73 - S73
  • [48] Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics
    Mahlich, Joerg
    Olbrich, Kerstin
    Wilk, Adrian
    Wimmer, Antonie
    Wolff-Menzler, Claus
    CLINICAL DRUG INVESTIGATION, 2021, 41 (01) : 99 - 113
  • [49] Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics
    Jörg Mahlich
    Kerstin Olbrich
    Adrian Wilk
    Antonie Wimmer
    Claus Wolff-Menzler
    Clinical Drug Investigation, 2021, 41 : 99 - 113
  • [50] Haloperidol versus atypical antipsychotics in the long-term treatment of schizophrenia
    Altamura, A. C.
    Buoli, M.
    Mauri, M. C.
    Dell'Osso, B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S466 - S466
12345